Speculation swirled around a report that a single patient -- a 79-year-old man -- was given access to a powerful new obesity drug that's still awaiting federal approval.
EXCLUSIVE: Eli Lilly gave compassionate use access to retatrutide, their unapproved powerful obesity drug, to a 79-year-old man in April. The application was arranged by a top doctor at NIH, and cleared by the FDA. www.statnews.com/2026/06/23/e ...